 |
|
|
|||||
Cipla shares: Following the earnings announcement, several brokerage firms revised their target price for the stock, with some estimates reaching as high as Rs 1,875 per share, indicating potential for further upside.
Category:
News and Media
Investors can apply for a minimum of 166 shares, with bids accepted in multiples, until the issue closes on July 28. Share allotment is likely on July 29, with the stock expected to list on both BSE and NSE on July 31. The IPO, pegging the companys valuation at over Rs 3,400 crore at the upper price band, is a pure fresh issue.
Category:
News and Media
Shriram Finance shares: Shriram Finance on Friday, July 25, reported a standalone net profit of Rs 2,156 crore for the AprilJune quarter, marking a 9% increase from Rs 1,981 crore in the same period last year. On a sequential basis, profit after tax rose 0.8% from Rs 2,139 crore in the JanuaryMarch quarter.
Category:
News and Media
Laurus Labs stock price increased following Andhra Pradesh government's land allotment. The company will establish Laurus Pharma Zone in Anakapalli district. Laurus Labs plans to invest significantly over eight years. This project aims to boost pharma manufacturing. It is also expected to generate employment opportunities for many people. Technical indicators suggest a potential short-term pullback, but overall sentiment remains positive.
Category:
News and Media
Indian pharma stocks are rebounding, driven by domestic investors after a period of Foreign Institutional Investor (FII) selling pressure. Uncertainty surrounding potential US tariffs, fueled by Trump's statements and delays in the Bilateral Trade Agreement (BTA), had initially impacted the sector. While FIIs remain cautious, positive earnings reports and the defensive nature of domestic-oriented pharma businesses are attracting DII interest.
Category:
News and Media
Sites : [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] next »